Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 17;32(11):1543-1546.
doi: 10.1097/QAD.0000000000001862.

Undisclosed antiretroviral drug use in Botswana: implication for national estimates

Sikhulile Moyo  1   2 , Simani Gaseitsiwe  1   2 , Kathleen M Powis  1   2   3 , Molly Pretorius Holme  1   2 , Terence Mohammed  1 , Melissa Zahralban-Steele  2 , Etienne K Yankinde  1 , Comfort Maphorisa  1 , William Abrams  4 , Refeletswe Lebelonyane  5 , Kutlo Manyake  1 , Tumalano Sekoto  1 , Mompati Mmalane  1 , Tendani Gaolathe  1 , Kathleen E Wirth  2 , Joseph Makhema  1 , Shahin Lockman  1   2   6 , William Clarke  7 , Max Essex  1   2 , Vlad Novitsky  1   2
Affiliations

Undisclosed antiretroviral drug use in Botswana: implication for national estimates

Sikhulile Moyo et al. AIDS. .

Abstract

: Among 3596 HIV-positive participants enrolled in the Botswana Combination Prevention Project who self-reported no prior antiretroviral (ARV) therapy use and were tested for viral load (n = 951; 27% of all participants), 136 (14%) had HIV-1 RNA less than 400 copies/ml. ARV drugs were detected in 52 (39%) of 134 participants tested. Adjusting for undisclosed ARV use increased the overall estimate of virally suppressed individuals on ARV therapy by 1.4% from 70.2 to 71.6%.

PubMed Disclaimer

Conflict of interest statement

Author Disclosure Statement

All authors have declared that no competing interest exists.

References

    1. Granich R, Gupta S, Hall I, Aberle-Grasse J, Hader S, Mermin J. Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review. PLoS Med. 2017;14(4):e1002253. - PMC - PubMed
    1. Granich R, Williams B, Montaner J, Zuniga JM. 90-90-90 and ending AIDS: necessary and feasible. Lancet. 2017;390(10092):341–343. - PubMed
    1. Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, et al. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med. 2017;14(5):e1002292. - PMC - PubMed
    1. Jain V, Petersen ML, Liegler T, Byonanebye DM, Kwarisiima D, Chamie G, et al. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis. The lancet HIV. 2017;4(3):e122–e133. - PMC - PubMed
    1. Petersen M, Balzer L, Kwarsiima D, Sang N, Chamie G, Ayieko J, et al. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa. JAMA. 2017;317(21):2196–2206. - PMC - PubMed

Publication types

LinkOut - more resources